4DMedical secures Stanford as first commercial site and expands AstraZeneca partnership in Brazil

4DMedical (ASX:4DX) has taken a significant step in the commercial rollout of its flagship CT:VQ technology. It announced that Stanford University has become the first US Academic Medical Centre to adopt the platform under a commercial agreement, less than two months after receiving clearance from the US Food and Drug Administration. …